Objectives:

1. Compare outcomes of various conventional treatments for post-allotransplant AML relapse, and gain awareness of experimental TCR T cell immunotherapy as a novel, personalized treatment

2. Explain the challenges of reconstructing tumor clonal evolution

3. Describe efforts to channel models of clonal evolution into real-time clinical decision making

Zoom Info:

Join from a PC, Mac, iPad, iPhone or Android device:

    Please click this URL to join. https://uwmadison.zoom.us/s/99207333842?pwd=Y3lOcXZUbnVaZzF4ay9DbWVFVzhpQT09

    Passcode: UWCCC

Or One tap mobile:

    +13126266799,,99207333842# US (Chicago)

    +19292056099,,99207333842# US (New York)

Or join by phone:

    Dial(for higher quality, dial a number based on your current location):

        US: +1 312 626 6799  or +1 929 205 6099  or +1 301 715 8592  or +1 346 248 7799  or +1 669 900 6833  or +1 253 215 8782

    Webinar ID: 992 0733 3842

    International numbers available: https://uwmadison.zoom.us/u/abKUgPvjOO